133162-24-0
133162-24-0
Chemical Structure
β-Aminoarteether
Synonym(s): SM934 free base
- CAS No.: 133162-24-0
- Formula:C17H29NO5
- Molecular Weight:327.42
IUPAC Name: 2-(((3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl)oxy)ethan-1-amine
InChIKey: HPGHCIXRRLNXRN-XQLAAWPRSA-N
SMILES: C[C@@H]1[C@@](CC[C@H]2C)([H])[C@@]([C@@]2([H])CC3)(OO4)[C@@](O[C@@H]1OCCN)([H])O[C@@]34C
Biological Activity: β-Aminoarteether (SM934 free base) is an Artemisinin derivative with orally active. β-Aminoarteether can be used for inflammation and autoimmune disease research, such as lupus diseases[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
β-Aminoarteether | 99.29% | β-Aminoarteether (SM934 free base) is an Artemisinin derivative with orally active. β-Aminoarteether can be used for inflammation and autoimmune disease research, such as lupus diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
α-Artemether | α-Artemether is an antimalarial compound. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
β-Aminoarteether maleate | β-Aminoarteether maleate (SM934) is an Artemisinin derivative with orally active. β-Aminoarteether maleate can be used for inflammation and autoimmune disease research, such as lupus diseases. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Artemotil | 99.91% | Artemotil (β-Arteether) has antimalarial activity for the treatment of chloroquine-resistant Plasmodium falciparum malaria with an IC50 of 1.61 nM. Artemotil also has central nervous system (CNS) neurotoxicity and anorectic toxicity in rats, dogs and monkeys. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dihydroartemisinin | 98.0% | Dihydroartemisinin is an orally active metabolite of rtemisinin (HY-B0094) and antimalarial agent. Dihydroartemisinin induces Autophagy by inhibiting NF-κB activation. Dihydroartemisinin promotes ROS accumulation. Dihydroartemisinin exhibits anticancer activity in esophageal cancer cells. Dihydroartemisinin shows schistosomicidal activity against juvenile and adult worms of Schistosoma japonicum, reduces worm burden, and displays antiparasitic activity. Dihydroartemisinin can be used in research related to multiple myeloma, promyelocytic leukemia, esophageal cancer, and Schistosoma japonicum infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dihydroartemisinin-d3 | Dihydroartemisinin-d3 (Dihydroqinghaosu-d3) is the d3-labeled Dihydroartemisinin (HY-N0176). Dihydroartemisinin is an orally active metabolite of rtemisinin (HY-B0094) and antimalarial agent. Dihydroartemisinin induces Autophagy by inhibiting NF-κB activation. Dihydroartemisinin promotes ROS accumulation. Dihydroartemisinin exhibits anticancer activity in esophageal cancer cells. Dihydroartemisinin shows schistosomicidal activity against juvenile and adult worms of Schistosoma japonicum, reduces worm burden, and displays antiparasitic activity. Dihydroartemisinin can be used in research related to multiple myeloma, promyelocytic leukemia, esophageal cancer, and Schistosoma japonicum infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Artesunate (Standard) | 99.84% | Artesunate (Standard) is the analytical standard of Artesunate. This product is intended for research and analytical applications. Artesunate is an inhibitor of both STAT-3 and exported protein 1 (EXP1). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Artemether | 98.38% | Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Artemether-d3 | 99.97% | Artemether-d3 is the deuterium labeled Artemether. Artemether is an antimalarial for the treatment of resistant strains of falciparum malaria. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dihydroartemisinin (mixture of α and β isomers) | 98.0% | Dihydroartemisinin (mixture of α and β isomers) is an anti-malaria and anticancer agent, as well as an active metabolite of artemisinin and its derivatives. Dihydroartemisinin exerts anticancer effects through various molecular mechanisms, such as inhibiting proliferation, inducing apoptosis, inhibiting tumor metastasis and angiogenesis, promoting immune function, inducing autophagy and endoplasmic reticulum stress. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
α-Artemether-d3 | α-Artemether-d3 (Methoxy-d3) is the deuterium labeled α-Artemether (HY-137217). α-Artemether is an antimalarial compound. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
